Evidence map›Paper›PMID 42129114›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

MIF NMR Chemical Shift Perturbation Mapping.

Emmanuel K Yeboah, Natalie A Borg, Stephen J Headey

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emmanuel K YeboahImmunity and Immune Evasion Laboratory, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, 3083, Australia.
Natalie A BorgImmunity and Immune Evasion Laboratory, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, 3083, Australia.
Stephen J HeadeySchool of Science, RMIT University, Melbourne, VIC, 3000, Australia. stephen.headey@rmit.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MIF, as a cytokine, is implicated in several disease classes, including cancer, autoimmunity, and viral infection, making it an attractive target for therapeutic development. Many biophysical techniques can provide estimates of binding affinity, which are helpful as compound screening techniques and invaluable in validating biological assay results. Among these techniques, Heteronuclear Single Quantum Coherence spectroscopy (HSQC) NMR offers significant advantages that justify its inherent technical challenges, including its high sensitivity, robustness to false positives, and the ability to determine binding affinities at micromolar to millimolar concentrations. Furthermore, by mapping the amino acids whose NMR chemical shift resonances are perturbed by compound binding onto the 3D structure of MIF, researchers can infer the binding site of the compound. Here, we present an isotopic

Indexed as

Macrophage Migration-Inhibitory FactorsNuclear Magnetic Resonance, BiomolecularBinding SitesHumansIsotope LabelingMagnetic Resonance SpectroscopyNitrogen IsotopesProtein BindingMacrophage Migration-Inhibitory FactorsNitrogen Isotopes15N-MIFChemical shift perturbation (CSP) mappingHSQC NMRMIF

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.